Aeglea BioTherapeutics


Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Industries

Employees

51-200

Links


Org chart

Russell J. Cox
Chief Executive Officer, Epirium Bio
Collapse
Cortney Caudill
Chief Product Officer
Eric Bradford
Chief Development Officer

Board & advisors